Skip to content

Clinical trials

Pulmonary Atelectasis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Atelectasis Country / region: China Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20181
20212
20235
20243
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting6
Unknown status4
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Zhongshan Hospital3
China Medical University, China2
Peking University People's Hospital2
Sixth Affiliated Hospital, Sun Yat-sen University2
Capital Medical University1
Dongyang Liu1
Fujian Medical University Union Hospital1
Guangzhou Institute of Respiratory Disease1
Jilai Xiao1
Northern Jiangsu People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Atelectasis20
Hypoxia2
Respiratory Distress Syndrome2
Bronchial Spasm1
Critical Illness1
Disease1
Lung Diseases1
Lung Injury1
Lung Neoplasms1
Obesity, Morbid1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.